Non-Invasive Hemoglobin Study

Completed

• Conditions: Anemia

• Registration Number: NCT02206399
• Lead Sponsor: Convergence Biometrics

Brief Summary

The investigators clinical trials will be for a medical device that is non-invasive in nature. The investigators will be studying whether their non-invasive medical device gets data that is as good as, or better than, an FDA previously approved, blood analysis device. There is no study hypothesis for this study.

Detailed Description

Not available

Study Timeline

• Study First Submitted: 2014-07-25
• Study First Submitted QC: 2014-07-31
• Study Start: 2014-08
• Study First Posted: 2014-08-01
• Primary Completion: 2014-11
• Study Completion: 2014-11
• Status Verified: 2016-06
• Last Update Submitted: 2016-06-24
• Last Update Posted: 2016-06-27

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 237

Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Percentage of Hemoglobin in Blood At Time of Test	Up to 30 seconds

Trial Locations

Locations (1)

BloodSource; 🇺🇸 Sacramento, California, United States